PharmaShots | Incisive News in 3 Shots

Subscribe Now

All Posts by Date

Disease of the Month: IgA Nephropathy

Disease of the Month: IgA Nephropathy

March 13, 2023

Sanofi to Acquire Provention Bio for ~$2.9B

Sanofi to Acquire Provention Bio for ~$2.9B

March 13, 2023

Calliditas’ Nefecon Meets its Primary Endpoint in P-III Trial (NefIgArd) for the Treatment of IgA Nephropathy

Calliditas’ Nefecon Meets its Primary Endpoint in P-III Trial (NefIgArd) for the Treatment of IgA Nephropathy

March 13, 2023

Acadia’s Daybue (trofinetide) Receives the US FDA’s Approval for Rett Syndrome in Adult and Pediatric Patients Aged ≥2Years

Acadia’s Daybue (trofinetide) Receives the US FDA’s Approval for Rett Syndrome in Adult and Pediatric Patients Aged ≥2Years

March 13, 2023

Guardant Health Reports the Submission of Premarket Approval Application to the US FDA for Shield Blood Test to Detect Colorectal Cancer

Guardant Health Reports the Submission of Premarket Approval Application to the US FDA for Shield Blood Test to Detect Colorectal...

March 13, 2023

AnnJi Entered into an Exclusive License Agreement with Avenue Therapeutics to Develop and Commercialize AJ201 for Kennedy's Disease

AnnJi Entered into an Exclusive License Agreement with Avenue Therapeutics to Develop and Commercialize AJ201 for Kennedy's Diseas...

March 13, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us